Hot Movers: Star Scientific, Cubist Pharmaceuticals, Cardium Therapeutics Inc., Alkermes Plc

Lakeway, NY -- (SBWIRE) -- 02/26/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Star Scientific, Inc. (NASDAQ:STSI) went down 0.53% and closed at $1.87. The 52-week range for the stock is $1.56 and $5.05. The Company has Price/Sales ratio of 50.55 and Price/Book ratio of 20.55. The 50-Day Moving Average and 200-Day Moving Average prices is $2.22 and $2.99 respectively. Star Scientific, Inc. is engaged in the manufacturing and production of dietary supplements. The Company’s operating subsidiaries manufacture, distribute and sell consumer products and dietary supplements. Its segment includes dietary supplements.

Get Latest News, Updates on STSI Here

Cubist Pharmaceuticals Inc. (NASDAQ:CBST) slipped 3.47% and closed at $41.12. Cubist Pharmaceuticals and Adynxx have entered into an option agreement under which Cubist has the exclusive right to acquire Adynxx following the data readout of Adynxx’s Phase 2 trial for its lead product candidate, AYX1. Adynxx, a privately held, clinical-stage pharmaceutical company focused on developing novel analgesic therapies, is studying AYX1 as a potential treatment for the reduction of acute pain and prevention of persistent and chronic pain following surgery.

Is CBST a Strong Buying Opportunity After The Recent Slump? Find out Here

Cardium Therapeutics Inc. (NYSEAMEX: CXM) closed at $0.172. The 52-week range for the stock is $0.15 and $0.30. The Company has Price/Sales ratio of 566.38 and Price/Book ratio of 2.69. The 50-Day Moving Average and 200-Day Moving Average prices is $0.19 and $0.20 respectively. Cardium Therapeutics, Inc. is focused on the acquisition and strategic development of product opportunities or businesses having the potential to address unmet medical needs.

Is CXM Signaling a Buy After The Sudden Gain? Don’t Miss Out Free Trend Analysis Here

Alkermes Plc. (NASDAQ:ALKS) decreased 2.16% and closed at $20.36. The Company announced that its corporate presentation will be webcast live at the 2013 RBC Capital Markets’ Healthcare Conference on February 26, 2013 from The New York Palace Hotel in New York City. The Alkermes corporate presentation will also be webcast live at Cowen and Company’s 33rd Annual Health Care Conference on Monday, March 4, 2013 from The Boston Marriott Copley Place in Boston.

Get latest News, Updates on ALKS Here

About ThePennyStockProfiler.com
ThePennyStockProfiler.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. ThePennyStockProfiler.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.ThePennyStockProfiler.com

Disclaimer
The assembled information disseminated by ThePennyStockProfiler.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. ThePennyStockProfiler.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.